Correction: Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor Sites

In this article (Cancer Res 2015;75:2520–9), which appeared in the June 15, 2015 issue of Cancer Research (1), the Grant Support section should have appeared as follows:

This work was supported by grants from NIH (UH2TR000875) and the Louisville Veterans Administration Medical Center (VAMC) Merit Review Grants (H.-G. Zhang). H.-G. Zhang is supported by a Research Career Scientist (RCS) Award, funded by U.S. Department of Veterans Affairs.